The Complement Receptor Type 2 (Cr2-145,CR2, CD21) is an important receptor
in the innate and acquired immune response. CD21 is produced by B cells an
d follicular dendritic cells, where it binds cleavage products of the C3 co
mplement protein. CD21 facilitates internalization of immune complexes by B
cells to enhance antigen presentation. CD21. in association with CD19/CD81
, also serves as a coaccessory activation complex with the B-cell antigen r
eceptor, permitting a lower antigen concentration to achieve maximal B-cell
activation. CD21 traps immune complexes on the surface of follicular dendr
itic cells and displays them to activated B cells in germinal centers. Much
work has been conducted to determine the transcriptional control mechanism
s dictating CD21 expression. Appropriate transcriptional control of the CD2
1 gene evidently requires the CD21 promoter, as well as intronic sequences
with enhancer and suppressor functions. Chromatin structure has been implic
ated in regulating the coordination of CD21 promoter and intronic control s
equences by regulating access to them by putative transcription Factors. Th
is review assesses the past and current research into CD21 transcriptional
regulation and offers insight into future experimental directions. (C) 2001
Elsevier Science B.V. All rights reserved.